Cargando…
A Framework for Navigating Institutional Review Board (IRB) Oversight in the Complicated Zone of Research
The treatment therapies and technologies currently emerging from the rapidly evolving health care industry must undergo full examination in a clinical setting if they are to be marketed to the public. All elements of clinical studies involving human subjects must undergo thorough IRB review before s...
Autor principal: | Parker, Gretchen E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120963/ https://www.ncbi.nlm.nih.gov/pubmed/27909632 http://dx.doi.org/10.7759/cureus.844 |
Ejemplares similares
-
Institutional review board (IRB) and ethical issues in clinical research
por: Kim, Won Oak
Publicado: (2012) -
Research Ethics Boards: No Data on Quality of For-Profit or Non-Profit IRBs
por: Shamoo, Adil E, et al.
Publicado: (2006) -
The Trouble With Too Much Board Oversight
por: Hoitash, Udi
Publicado: (2013) -
Performance of IRBs in China: a survey on IRB employees and researchers’ experiences and perceptions
por: Liu, Xing, et al.
Publicado: (2022) -
A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials
por: Rose, Klaus, et al.
Publicado: (2015)